Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Foot deformity
ADR ID BADD_A08515
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.10      Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)
15.10.03      Extremity deformities
15.10.03.005      Foot deformity
Description Alterations or deviations from normal shape or size which result in a disfigurement of the foot. [MeSH]
MedDRA Code 10061159
MeSH ID D005530; D000071378; D005413; D006215; D037801; D000070589; D000070592; D000070591; D050489
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Acquired deformities of toe | Acquired equinovarus deformity | Bunion | Cavovarus deformity of foot, acquired | Cavus deformity of foot, acquired | Claw foot, acquired | Claw toe (acquired) | Equinus deformity of foot, acquired | Fallen arches | Flat feet | Flat foot | Foot deformity NOS | Hallux malleus | Hallux valgus | Hallux valgus (acquired) | Hallux varus (acquired) | Hammer toe | Other acquired calcaneus deformity | Other acquired deformities of toe | Other hammer toe (acquired) | Pes cavus | Pes planus | Pes valgus | Toe deformities (acquired) | Toe deformities NOS | Unspecified acquired deformity of toe | Acquired claw toe | Foot deformity | Toe deformity | Pigeon toe | In-toeing | Out-toeing | Metatarsus primus elevatus | Splayfoot | Talipes valgus acquired | Bunionette | Gastrocnemius equinus | Foot inversion deformity | Foot eversion deformity | Foot overpronation | Plantarflexed metatarsal | Curly toe | Pes planovalgus | Positional talipes equinovarus | Claw toe | Foot Deformities | Deformities, Foot | Deformity, Foot | Foot Deformity | Metatarsal Deformity | Deformities, Metatarsal | Deformity, Metatarsal | Metatarsal Deformities
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01950Risedronic acid--
BADD_D01971Rosuvastatin0.000017%
BADD_D02010Sertraline0.000045%
BADD_D02026Simvastatin0.000018%
BADD_D02093Sulfasalazine--
BADD_D02105Tacrolimus0.000297%
BADD_D02165Teriflunomide0.000772%
BADD_D02236Tofacitinib0.023243%
BADD_D02329Valproic acid0.002646%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02407Upadacitinib0.000651%
BADD_D02412Octreotide--
BADD_D02464Fingolimod0.001495%
BADD_D02487Baricitinib--
The 2th Page    First    Pre   2    Total 2 Pages